>>> Up
* Biogen Raised to Overweight at JPMorgan; PT $300
* Brown & Brown Raised to Outperform at KBW; PT $77
* Carlsberg Raised to Equal-Weight at Barclays; PT 930 kroner
* Cranswick Raised to Buy at Peel Hunt; PT 6,600 pence
* Danske Bank Raised to Buy at Arctic Securities; PT 390 kroner
* Dom Dev Raised to Buy at Trigon Dom Maklerski; PT 285 zloty (+)
* I Grandi Viaggi Raised to Buy at Banca Akros (ESN) (+)
* Meko Raised to Buy at SB1 Markets; PT 90 kronor
* Meko Raised to Buy at SB1 Markets; PT 90 kronor
* Nexans Raised to Buy at Jefferies; PT 158 euros
* Sparebank 1 Ostfold Akershus Raised to Buy at SB1 Markets
* Standard Life Raised to Outperform at RBC; PT 950 pence
* T-Mobile Raised to Outperform at Raymond James; PT $170 (+)
* Tryg Raised to Neutral at Goldman; PT 158 kroner
>>> Down
>>> Down
* Aroundtown Cut to Sell at Goldman; PT 1.30 euros
* FlatexDEGIRO Cut to Hold at Deutsche Bank; PT 31 euros (+)
* Handelsbanken Cut to Sell at Arctic Securities; PT 134 kronor
* KH Group Oyj Cut to Reduce at Inderes; PT 90 euro cents
* Microsoft Cut to Neutral at Phillip Secs; PT $515
* OPmobility Cut to Neutral at Citi; PT 11 euros
* Palantir Cut to Neutral at Phillip Secs; PT $215
* Pennon Cut to Hold at Deutsche Bank; PT 380 pence
* Pennon Cut to Hold at Deutsche Bank; PT 380 pence
* Snowflake Cut to Accumulate at Phillip Secs; PT $423
* SRV Group Cut to Reduce at Inderes; PT 9.70 euros
* TF1 PT Cut to 6.50 euros from 7.50 euros at CIC (+)
>>> Initiation
>>> Initiation
* Boliden Rated New Buy at Nordea; PT 650 kronor
* CVC Capital Rated New Overweight at Morgan Stanley; PT 18 euros
* Ebro Motors Group EV Rated New Buy at NuWays; PT 14.50 euros (+)
* Hermes Rated New Buy at SBG Securities; PT 1,623 euros (+)
* International Workplace Rated New Buy at Goldman; PT 270 pence (+)
* Kering Rated New Buy at SBG Securities; PT 233 euros (+)
* LVMH Reinstated Buy at SBG Securities; PT 425 euros (+)
* Remy Cointreau Rated New Buy at Invest Securities SA (+)
* Siemens Energy Rated new Sell, PT €125 at Panmure Gordon
* Siemens Rated new Buy, PT €325 at Panmure Gordon
* Spyre Therapeutics Inc Rated New Buy at UBS; PT $120
>>> Call
* Spyre Therapeutics Inc Rated New Buy at UBS; PT $120
>>> Call
* Goldman Turns Overweight Stocks for 3 Months on Earnings Growth
* Carlsberg Loses Only Sell as Barclays Sees Improvement in Growth
* Carlsberg Loses Only Sell as Barclays Sees Improvement in Growth
* Cranswick Has Clean Sweep of Buy Ratings After Peel Hunt Upgrade (+)
* CVC Overweight at Morgan Stanley on ‘Underappreciated Breadth’
* Morgan Stanley’s Wilson Says to Stick With US Quality Stocks (+)
* Nexans Upgraded to Buy at Jefferies on Improving Fundamentals (+)
* OPmobility Earnings Outlook Less Certain Post-Warning, Citi Cuts
* Standard Life Raised to Outperform at RBC After Selloff (+)